Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01182
Species: Homo sapiens
Position : chr3:111274001-111275000
Year: 2025
Title: Enhancer activation from transposable elements in extrachromosomal DNA.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: colorectal adenocarcinoma
PMID:  41120733
MONDO: MONDO:0005008
Tissue: sigmoid colon
Tissue Ontology ID: UBERON:0001159
Cell Source: COLO320DM
CVCL ID: CVCL_0219
Cell Type: colon epithelial cell, adenocarcinoma-derived
Cell Ontology ID: CL:0011108
Experiment Type: Enhancer activity assay; endogenous epigenetic perturbation; ecDNA structural mapping; chromatin-interaction mapping; 3D spatial interaction analysis; chromatin-state profiling; transcriptional imaging; cancer-cell fitness assay; Endogenous enhancer perturbation
High Throughput Method: Hi-C; Oxford Nanopore ultra-long-read whole-genome sequencing with CoRAL ecDNA reconstruction; pooled CRISPRi fitness screen with deep sequencing; re-analysis of ATAC-seq; H3K27ac ChIP-seq; BRD4 ChIP-seq
Low Throughput Method: CRISPR-CATCH with PFGE and targeted sequencing; ORCA 3D DNA imaging; DNA-FISH; RNA-FISH; dual-luciferase enhancer assay using MYC and TK promoters; L1PA2/L1M4a1 fragment reporter assays; metaphase-spread ecDNA validation; CRISPRi; CRISPR-CATCH; Reporter assay
About Target Gene
Target gene : MYC
About TF
TF name : NA
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19) 1 found
Enhancer ID Position Tissue Cell Disease
E_01173 chr3:111274001-111275000 sigmoid colon colon epithelial cell, adenocarcinoma-derived colorectal adenocarcinoma
Expression of Target Genes for the Enhancer